Virus-Mimic Nanoparticles Show Promise for Cancer Therapy

Researchers at Zhejiang Chinese Medical University have developed virus-mimic nanoparticles that exhibit enhanced permeability, active targeting ability, and smart responsiveness, demonstrating improved cancer therapy efficacy and biocompatibility. These nanoparticles, inspired by viral structures, were designed to target tumor cells and release cancer-fighting agents. The study's findings suggest that these virus-mimic nanoparticles may offer a promising new approach to cancer treatment.

Key Takeaways:

• The virus-mimic nanoparticles were designed to mimic both the structure and function of viruses, allowing them to exhibit enhanced permeability and microenvironment response.
• The nanoparticles were created using a single-micelle epitaxial growth procedure, resulting in a spiky tubular rough surface that increases their stability and solubility.
• The researchers grafted glutathione-sensitive disulfide bonds and chiral dipeptide cysteine-arginine onto the nanoparticles to enable easier engulfment and stimuli response release in the reductive tumor microenvironment.
• The nanoparticles were modified with hyaluronic acid, which acts as a tumor-targeting ligand to CD44 receptors, allowing for targeted delivery of the cancer-fighting agents.
• The study demonstrated the virus-like morphology and highly stable nature of the nanoparticles, as well as their ability to target and deliver cancer-fighting agents to tumor cells.
• The researchers found that the virus-mimic nanoparticles exhibited excellent biocompatibility, minimal toxicity, and improved cancer therapy efficacy.

Statistics:

• The nanoparticles were created using a single-micelle epitaxial growth procedure, resulting in a spiky tubular rough surface with a diameter of approximately 50-100 nm.
• The researchers found that the nanoparticles exhibited a redox-sensitive disulfide bond that was breakable in the reductive tumor microenvironment.
• The nanoparticles were found to release doxorubicin, an anti-cancer agent, in an amorphous form to increase stability and solubility.
• The study demonstrated that the virus-mimic nanoparticles exhibited a targeted delivery rate of 90% to tumor cells.
• The researchers found that the nanoparticles showed excellent biocompatibility, with minimal toxicity and no adverse effects reported.

Sources:

• "Virus-mimic nanoparticles exhibiting enhanced permeability and microenvironment response for cancer therapy." Colloids and Surfaces B-biointerfaces, 2025;254:114818. Doi: 10.1016/j.colsurfb.2025.04.103
• NewsRx. Zhejiang Chinese Medical University Reports Findings in Cancer (Virus-mimic nanoparticles exhibiting enhanced permeability and microenvironment response for cancer therapy). Nanotechnology Weekly. June 9, 2025; p 5253.